A key part of developing the protocol for our study is defining what will constitute the palliative care arm of the study, meaning what will those patients randomized to palliative care receive that the control group will not? There are many details that I won't get into. But, in the discussion of what the palliative care intervention would be like, an interesting question was asked.
- What is the difference between palliative care and disease management?
Sometimes the simplest questions are the hardest to answer. Does anyone have any thoughts about the differences between palliative care and disease management? Generally, or in the case of CHF, specifically?